Blueprint Medicines Corp (BPMC)
102.39
-0.32
(-0.31%)
USD |
NASDAQ |
May 23, 16:00
102.39
0.00 (0.00%)
After-Hours: 17:14
Blueprint Medicines Accounts Payable (Quarterly): 4.926M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.926M |
December 31, 2023 | 4.71M |
September 30, 2023 | 6.963M |
June 30, 2023 | 6.979M |
March 31, 2023 | 10.56M |
December 31, 2022 | 2.729M |
September 30, 2022 | 4.233M |
June 30, 2022 | 15.05M |
March 31, 2022 | 17.96M |
December 31, 2021 | 8.333M |
September 30, 2021 | 9.549M |
June 30, 2021 | 1.847M |
March 31, 2021 | 2.889M |
December 31, 2020 | 4.37M |
September 30, 2020 | 2.929M |
June 30, 2020 | 5.591M |
March 31, 2020 | 8.468M |
December 31, 2019 | 4.793M |
September 30, 2019 | 2.203M |
Date | Value |
---|---|
June 30, 2019 | 6.608M |
March 31, 2019 | 4.421M |
December 31, 2018 | 3.298M |
September 30, 2018 | 3.988M |
June 30, 2018 | 2.98M |
March 31, 2018 | 3.288M |
December 31, 2017 | 3.744M |
September 30, 2017 | 2.092M |
June 30, 2017 | 2.581M |
March 31, 2017 | 2.282M |
December 31, 2016 | 2.211M |
September 30, 2016 | 1.848M |
June 30, 2016 | 2.73M |
March 31, 2016 | 2.773M |
December 31, 2015 | 2.455M |
September 30, 2015 | 1.562M |
June 30, 2015 | 1.611M |
March 31, 2015 | 2.334M |
December 31, 2014 | 0.814M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.847M
Minimum
Jun 2021
17.96M
Maximum
Mar 2022
6.585M
Average
5.258M
Median
Accounts Payable (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 1.893M |
Biomarin Pharmaceutical Inc | 292.24M |
Apellis Pharmaceuticals Inc | 26.79M |
Alnylam Pharmaceuticals Inc | 78.15M |
Cytokinetics Inc | 12.97M |